Advertisement
Screener

CASI PHARMACEUTICALS, INC. (CASIF) Lessee, Operating Lease, Liability, Undiscounted Excess Amount

2.1 / 5 stars · 17/40 Roast Me

CASI PHARMACEUTICALS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount

CASI PHARMACEUTICALS, INC. (CASIF) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $158.00 thousand as of 2025-12-31, per its 20-F filed 2026-05-15.

Financial Statements › Notes › Leases

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-05-15

  • 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $158.00K.
  • 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $273.00K.
  • 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $238.00K.
  • 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $37.00K.
Period endLessee, Operating Lease, Liability, Undiscounted Excess Amount
2025-12-31$158.00K
20-F · filed 2026-05-15
2024-12-31$273.00K
20-F · filed 2025-03-31
2023-12-31$238.00K
20-F · filed 2024-03-28
2022-12-31$37.00K
20-F · filed 2023-04-26